Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
0.725
-0.022 (-2.99%)
At close: Dec 5, 2025, 4:00 PM EST
0.760
+0.035 (4.87%)
After-hours: Dec 5, 2025, 7:41 PM EST

Company Description

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.

The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.

The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.

Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Intelligent Bio Solutions Inc.
Intelligent Bio Solutions logo
Country United States
Founded 2016
Industry Medical Devices
Sector Healthcare
Employees 55
CEO Harry Simeonidis

Contact Details

Address:
135 West, 41st Street, 5th Floor
New York, New York 10036
United States
Phone 646 828 8258
Website ibs.inc

Stock Details

Ticker Symbol INBS
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001725430
CUSIP Number 36151G600
ISIN Number US36151G6008
Employer ID 82-1512711
SIC Code 3841

Key Executives

Name Position
Harry Simeonidis President and Chief Executive Officer
Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law Chief Financial Officer
Callistus Sequeira Vice President of Global Quality and Operations
Doug Heath Vice President of Global Sales
Anna Turkington Vice President of Marketing

Latest SEC Filings

Date Type Title
Dec 5, 2025 S-8 Securities to be offered to employees in employee benefit plans
Dec 2, 2025 8-K Current Report
Nov 28, 2025 8-K Current Report
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 12, 2025 8-K Current Report
Nov 12, 2025 10-Q Quarterly Report
Nov 7, 2025 8-K Current Report
Oct 30, 2025 8-K Current Report
Oct 21, 2025 8-K Current Report
Sep 26, 2025 8-K Current Report